13 Aug. 2020. A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. Micronoma, in San Diego, is also raising $3 million in its seed funding round, equity financing gained at or soon after start-up.

Micronoma is licensing discoveries by its scientific founders at the Center for Microbiome Innovation at University of California in San Diego, part of the university’s engineering school. Research at the center by Micronoma’s scientific founders Greg Poore, an M.D./Ph.D. candidate, and Rob Knight, the center’s director, highlight contributions of cancer-related microbes in detecting the disease. Read Article